GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » COGS-to-Revenue

SPO Global (SPO Global) COGS-to-Revenue : 0.67 (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is SPO Global COGS-to-Revenue?

SPO Global's Cost of Goods Sold for the three months ended in Sep. 2023 was $3.13 Mil. Its Revenue for the three months ended in Sep. 2023 was $4.66 Mil.

SPO Global's COGS to Revenue for the three months ended in Sep. 2023 was 0.67.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. SPO Global's Gross Margin % for the three months ended in Sep. 2023 was 32.80%.


SPO Global COGS-to-Revenue Historical Data

The historical data trend for SPO Global's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global COGS-to-Revenue Chart

SPO Global Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.74 0.08 0.04 -

SPO Global Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep22 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.67

SPO Global COGS-to-Revenue Calculation

SPO Global's COGS to Revenue for the fiscal year that ended in Dec. 2016 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.115
=0.00

SPO Global's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.128 / 4.655
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SPO Global  (OTCPK:SPOM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

SPO Global's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3.128 / 4.655
=32.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


SPO Global COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of SPO Global's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SPO Global (SPO Global) Business Description

Traded in Other Exchanges
N/A
Address
Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634
SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.
Executives
Jeffrey Louis Feuer officer: Chief Financial Officer 21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan officer: Chief Operating Officer 21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold director, officer: Chief Executive Officer C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun director SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman director 183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi 10 percent owner, officer: Chief Technology Officer C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367